These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

411 related items for PubMed ID: 29659938

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Second primary neoplasms following non-Hodgkin's lymphoma in New South Wales, Australia.
    Brennan P, Coates M, Armstrong B, Colin D, Boffetta P.
    Br J Cancer; 2000 Apr; 82(7):1344-7. PubMed ID: 10755412
    [Abstract] [Full Text] [Related]

  • 24. Merkel cell carcinoma and multiple primary cancers.
    Howard RA, Dores GM, Curtis RE, Anderson WF, Travis LB.
    Cancer Epidemiol Biomarkers Prev; 2006 Aug; 15(8):1545-9. PubMed ID: 16896047
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Second malignancy risks after non-Hodgkin's lymphoma and chronic lymphocytic leukemia: differences by lymphoma subtype.
    Morton LM, Curtis RE, Linet MS, Bluhm EC, Tucker MA, Caporaso N, Ries LA, Fraumeni JF.
    J Clin Oncol; 2010 Nov 20; 28(33):4935-44. PubMed ID: 20940199
    [Abstract] [Full Text] [Related]

  • 28. Risk of second primary cancers, other than melanoma, in an Italian population-based cohort of cutaneous malignant melanoma patients.
    Crocetti E, Carli P.
    Eur J Cancer Prev; 2004 Feb 20; 13(1):33-7. PubMed ID: 15075786
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Risk of second primary breast cancer among cancer survivors: Implications for prevention and screening practice.
    Cheng Y, Huang Z, Liao Q, Yu X, Jiang H, He Y, Yao S, Nie S, Liu L.
    PLoS One; 2020 Feb 20; 15(6):e0232800. PubMed ID: 32497148
    [Abstract] [Full Text] [Related]

  • 32. Trends in the Risks of Secondary Cancers in Patients With Hodgkin Lymphoma.
    Kumar V, Garg M, Chandra AB, Mayorga VS, Ahmed S, Ailawadhi S.
    Clin Lymphoma Myeloma Leuk; 2018 Sep 20; 18(9):576-589.e1. PubMed ID: 29934060
    [Abstract] [Full Text] [Related]

  • 33. Risk for subsequent cancer after diagnosis of basal-cell carcinoma. A population-based, epidemiologic study.
    Frisch M, Hjalgrim H, Olsen JH, Melbye M.
    Ann Intern Med; 1996 Nov 15; 125(10):815-21. PubMed ID: 8928988
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Risk of subsequent primary lymphoma in a cohort of 69,460 five-year survivors of childhood and adolescent cancer in Europe: The PanCareSurFup study.
    Dudley IM, Sunguc C, Heymer EJ, Winter DL, Teepen JC, Belle FN, Bárdi E, Bagnasco F, Gudmundsdottir T, Skinner R, Michel G, Byrne J, Øfstaas H, Jankovic M, Mazić MČ, Mader L, Loonen J, Garwicz S, Wiebe T, Alessi D, Allodji RS, Haddy N, Grabow D, Kaatsch P, Kaiser M, Maule MM, Jakab Z, Gunnes MW, Terenziani M, Zaletel LZ, Kuehni CE, Haupt R, de Vathaire F, Kremer LC, Lähteenmäki PM, Winther JF, Hjorth L, Hawkins MM, Reulen RC.
    Cancer; 2023 Feb 01; 129(3):426-440. PubMed ID: 36444554
    [Abstract] [Full Text] [Related]

  • 36. Risk of second malignancies in survivors of retinoblastoma: more than 40 years of follow-up.
    Marees T, Moll AC, Imhof SM, de Boer MR, Ringens PJ, van Leeuwen FE.
    J Natl Cancer Inst; 2008 Dec 17; 100(24):1771-9. PubMed ID: 19066271
    [Abstract] [Full Text] [Related]

  • 37. Subsequent neoplasms in 5-year survivors of childhood cancer: the Childhood Cancer Survivor Study.
    Friedman DL, Whitton J, Leisenring W, Mertens AC, Hammond S, Stovall M, Donaldson SS, Meadows AT, Robison LL, Neglia JP.
    J Natl Cancer Inst; 2010 Jul 21; 102(14):1083-95. PubMed ID: 20634481
    [Abstract] [Full Text] [Related]

  • 38. Risk of cutaneous T-cell lymphoma in patients with chronic lymphocytic leukemia and other subtypes of non-Hodgkin lymphoma.
    Chang TW, Weaver AL, Shanafelt TD, Habermann TM, Wriston CC, Cerhan JR, Call TG, Brewer JD.
    Int J Dermatol; 2017 Nov 21; 56(11):1125-1129. PubMed ID: 28685851
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Risks for noncutaneous second primary malignancy in cutaneous malignant melanoma survivors: an analysis of data from the Surveillance, Epidemiology, and End Results (SEER) program.
    Vakharia PP, Kelm RC, Orrell KA, Patel KR, Singam V, Ali Y, Rastogi S, Yousif R, Rangel SM, West DP, Nardone B.
    Int J Dermatol; 2020 Apr 21; 59(4):463-468. PubMed ID: 31971260
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 21.